US20020098114A1 - Microdroplet dispensing for a medical diagnostic device - Google Patents

Microdroplet dispensing for a medical diagnostic device Download PDF

Info

Publication number
US20020098114A1
US20020098114A1 US10/061,723 US6172302A US2002098114A1 US 20020098114 A1 US20020098114 A1 US 20020098114A1 US 6172302 A US6172302 A US 6172302A US 2002098114 A1 US2002098114 A1 US 2002098114A1
Authority
US
United States
Prior art keywords
reagent
substrate
sample
area
stream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/061,723
Inventor
Ian Harding
Robert Shartle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScan Inc
Original Assignee
LifeScan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/333,765 external-priority patent/US6521182B1/en
Application filed by LifeScan Inc filed Critical LifeScan Inc
Priority to US10/061,723 priority Critical patent/US20020098114A1/en
Assigned to LIFESCAN, INC. reassignment LIFESCAN, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HARDING, IAN A., SHARTLE, ROBERT JUSTICE
Publication of US20020098114A1 publication Critical patent/US20020098114A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/14Devices for taking samples of blood ; Measuring characteristics of blood in vivo, e.g. gas concentration within the blood, pH-value of blood
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D3/00Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502707Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4905Determining clotting time of blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521Single-layer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5302Apparatus specially adapted for immunological test procedures
    • G01N33/5304Reaction vessels, e.g. agglutination plates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54386Analytical elements
    • G01N33/54387Immunochromatographic test strips
    • G01N33/54388Immunochromatographic test strips based on lateral flow
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0621Control of the sequence of chambers filled or emptied
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/12Specific details about manufacturing devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/16Reagents, handling or storing thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/06Auxiliary integrated devices, integrated components
    • B01L2300/0681Filter
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0822Slides
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0825Test strips
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0864Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/087Multiple sequential chambers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0887Laminated structure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0406Moving fluids with specific forces or mechanical means specific forces capillary forces
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0475Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0481Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure squeezing of channels or chambers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/06Valves, specific forms thereof
    • B01L2400/0688Valves, specific forms thereof surface tension valves, capillary stop, capillary break
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84Systems specially adapted for particular applications
    • G01N21/8483Investigating reagent band
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/7454Tissue factor (tissue thromboplastin, Factor III)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)
    • G01N2333/96441Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96447Factor VII (3.4.21.21)

Definitions

  • This invention relates to a medical diagnostic device that is prepared by nonimpact printing; more particularly, by nonimpact printing of a reagent onto a hydrophilic surface of the device.
  • a variety of medical diagnostic procedures involve tests on biological fluids, such as blood, urine, or saliva, and are based on a change in a physical characteristic of such a fluid or an element of the fluid, such as blood serum.
  • the characteristic can be an electrical, magnetic, fluidic, or optical property.
  • optical property When an optical property is monitored, these procedures may make use of a transparent or translucent device to contain the biological fluid and a reagent.
  • a change in light absorption of the fluid can be related to an analyte concentration in, or property of, the fluid.
  • a light source is located adjacent to one surface of the device and a detector is adjacent to the opposite surface. The detector measures light transmitted through a fluid sample.
  • the light source and detector can be on the same side of the device, in which case the detector measures light scattered and/or reflected by the sample.
  • a reflector may be located at or adjacent to the opposite surface.
  • References to “light” throughout this specification and the appended claims should be understood to include the infrared and ultraviolet spectra, as well as the visible. References to “absorption” are meant to refer to the reduction in intensity as a light beam passes through a medium; thus, it encompasses both “true” absorption and scattering.
  • FIG. 1 An example of a transparent test device is described in Wells et al. W094/02850, published on Feb. 3, 1994.
  • Their device comprises a sealed housing, which is transparent or translucent, impervious, and rigid or semi-rigid.
  • An assay material is contained within the housing, together with one or more assay reagents at predetermined sites.
  • the housing is opened and the sample introduced just before conducting the assay.
  • the combination of assay reagents and analyte in the sample results in a change in optical properties, such as color, of selected reagents at the end of the assay.
  • the results can be read visually or with an optical instrument.
  • the indicator includes a “half-bulb cavity”, which is compressible.
  • the bulb is compressed and released to form a suction that draws fluid from a source, through a half-tubular cavity that has an indicator imprinted on its wall.
  • the only controls on fluid flow into the indicator are how much the bulb is compressed and how long the indicator inlet is immersed in the source, while the bulb is released.
  • U.S. Pat. 3,640,267 issued on Feb. 8, 1972 to Hurtig et al., discloses a container for collecting samples of body fluid that includes a chamber that has resilient, collapsible walls. The walls are squeezed before the container inlet is placed into the fluid being collected. When released, the walls are restored to their uncollapsed condition, drawing fluid into and through the inlet. As with the Davis device, discussed above, control of fluid flow into the indicator is very limited.
  • U.S. Pat. No. 4,088,448, issued on May 9, 1978 to Lilja et al. discloses a cuvette, which permits optical analysis of a sample mixed with a reagent.
  • the reagent is coated on the walls of a cavity, which is then filled with a liquid sample.
  • the sample mixes with the reagent to cause an optically-detectable change.
  • test devices described above and in the cited references typically comprise a dry strip having a reagent coated on one or more predetermined positions. Applying these reagents to their intended positions on large numbers of these devices can, in principle, be accomplished by standard printing processes; however, nonimpact printing provides some distinct advantages. For example, nonimpact printers can be smaller, lighter, and less expensive, since they don't have to endure the repeated impact of print head on substrate. They also permit the use of transparent substrates, as required for optical devices that involve changes in light transmission. Information on the varieties of nonimpact printing appears in J. L. Johnson, Principles of Nonimpact Printing, 3d ed., Palatino Press, Irvine, Calif. 1998 .
  • a piezo-electric print head was used.
  • the ink-jet printer used was a Hewlett-Packard ThinkjetTM printer, which is a thermal ink-jet printer (see Hewlett-Packard Journal, May, 1985).
  • the element is fabricated by ink-jet printing of reagents in a series of “compartments,” using a thermal ink-jet print head.
  • the present invention provides a method for preparing a medical diagnostic reagent device, comprising the steps of
  • a diagnostic reagent device of the present invention measures an analyte concentration or characteristic of a biological fluid and comprises
  • the sample application and reagent areas may coincide or, alternatively, be spaced apart, with an intermediate path to convey the sample.
  • the measurement is generally, but not necessarily, made when the sample is on the reagent area, and in the description below, the measurement of interest is made when the sample is in the reagent area.
  • the method is particularly well adapted for preparing a device for measuring prothrombin time (PT time), with the target area being coated with a reagent composition that catalyzes the blood clotting cascade.
  • the diagnostic reagent strip of the invention is particularly well adapted for measuring the PT time of a whole blood sample.
  • microdroplet refers to droplets having a volume in the range from about 1 picoliter to 1 microliter.
  • FIG. 1 is a plan view of a device of the present invention.
  • FIG. 2 is an exploded vies of the device of FIG. 1.
  • FIG. 3 is a perspective view of the device of FIG.
  • FIG. 4 is a schematic of a meter for use with a device of this invention.
  • FIG. 5 is a graph of data that is used to determine PT time.
  • FIG. 6 is a plan view of an alternative embodiment of a device of this invention.
  • FIG. 7 is a plan view of a coating prepared by the method of the present invention.
  • FIG. 8 is a schematic of a nonimpact printing process of this invention.
  • FIG. 9 is a graph that demonstrates an advantage of the present invention.
  • the medical diagnostic reagent device of this invention is prepared by depositing a reagent upon a hydrophilic “reagent area” of a non-absorbent substrate by a nonimpact printing process.
  • the device is of the type that relates a physical parameter of a biological fluid, or an element of the fluid, to an analyte concentration in the fluid or to a property of the fluid.
  • physical parameters e.g., electrical, magnetic, fluidic, or optical
  • a preferred embodiment of the device includes a planar substrate, such as a thermoplastic sheet.
  • the substrate has on its surface a sample application area and the reagent area, in which the sample undergoes a change in an optical parameter, such as light scattering.
  • the substrate, or “bottom layer,” forms with “intermediate” and “top” layers a bladder, to create a suction force to draw the sample into the device, and a stop junction, to precisely stop flow after filling the reagent area.
  • the device is substantially transparent over the reagent area, so that the area can be illuminated by a light source on one side and the transmitted light measured on the opposite side.
  • the nonimpact-printed reagent causes the sample to undergo a change, and the change in transmitted light is a measure of the analyte or fluid property of interest.
  • light that is scattered from a fluid sample or light that passes through the sample and is reflected back through a second time can be detected by a detector on the same side as the light source.
  • This type of device is suitable for a variety of analytical tests of biological fluids, such as determining biochemical or hematological characteristics, or measuring the concentration in such fluids of proteins, hormones, carbohydrates, lipids, drugs, toxins, gases, electrolytes, etc.
  • analytical tests of biological fluids, such as determining biochemical or hematological characteristics, or measuring the concentration in such fluids of proteins, hormones, carbohydrates, lipids, drugs, toxins, gases, electrolytes, etc.
  • the procedures for performing these tests have been described in the literature. Among the tests, and where they are described, are the following:
  • Chromogenic Factor XIIa Assay (and other clotting factors as well): Rand, M. D. et al., Blood, 88, 3432 (1996).
  • TPA Assay Mann, K. G., et al., Blood, 76, 755, (1990).; and Hartshorn, J. N. et al., Blood, 78, 833 (1991).
  • APTT Activated Partial Thromboplastin Time Assay: Proctor, R. R. and Rapaport, S. I. Amer. J. Clin. Path, 36, 212 (1961); Brandt, J. T. and Triplett, D. A. Amer. J. Clin. Path., 76, 530 (1981); and Kelsey, P. R. Thromb. Haemost. 52, 172 (1984).
  • HbAlc Assay (Glycosylated Hemoglobin Assay): Nicol, D. J. et al., Clin. Chem. 29, 1694 (1983).
  • the present device is particularly well suited for measuring blood-clotting time—“prothrombin time” or “PT time”—and details regarding such a device appear below.
  • the modifications needed to adapt the device for applications such as those listed above require no more than routine experimentation.
  • FIG. 1 is a plan view of a device 10 of the present invention.
  • FIG. 2 is an exploded view and FIG. 3 a perspective view of the device.
  • Sample is applied to sample port 12 after bladder 14 has been compressed.
  • the region of layer 26 and/or layer 28 that adjoins the cutout for bladder 14 must be resilient, to permit bladder 14 to be compressed.
  • Polyester of about 0.1 mm thickness has suitable resilience and springiness.
  • top layer 26 has a thickness of about 0.125 mm, bottom layer 28 about 0.100 mm.
  • the volume of bladder 14 is preferably at least about equal to the combined volume of channel 16 and reagent area 18 . If-reagent area 18 is to be illuminated from below, layer 28 must be transparent where it adjoins reagent area 18 .
  • reagent 20 contains thromboplastin that is free of bulking reagents normally found in lyophilized reagents.
  • stop junction 22 adjoins bladder 14 and reagent area 18 ; however, a continuation of channel 16 may be on either or both sides of stop junction 22 , separating the stop junction from reagent area 18 and/or bladder 14 .
  • sample flow stops When the sample reaches stop junction 22 , sample flow stops.
  • the principle of operation of stop junctions is described in U.S. Pat. No. 5,230,866, incorporated herein by reference.
  • all the above elements are formed by cutouts in intermediate layer 24 , sandwiched between top layer 26 and bottom layer 28 .
  • layer 24 is double-sided adhesive tape.
  • Stop junction 22 is formed by an additional cutout in layer 26 and/or 28 , aligned with the cutout in layer 24 and sealed with sealing layer 30 and/or 32 .
  • the stop junction comprises cutouts in both layers 26 and 28 , with sealing layers 30 and 32 .
  • Each cutout for stop junction 22 is at least as wide as channel 16 .
  • an optional filter 12 A to cover sample port 12 .
  • the filter may separate out red blood cells from a whole blood sample and/or may contain a reagent to interact with the blood to provide additional information.
  • a suitable filter comprises an anisotropic membrane, preferably a polysulfone membrane of the type available from Spectral Diagnostics, Inc., Toronto, Canada.
  • Optional reflector 18 A may be on, or adjacent to, a surface of layer 26 and positioned over reagent area 18 . If the reflector is present, the device becomes a transflectance device.
  • FIGS. 1, 2, and 3 The method of using the strip of FIGS. 1, 2, and 3 can be understood with reference to a schematic of the elements of a meter shown in FIG. 4, which contemplates an automated meter. Alternatively, manual operation is also possible. (In that case, bladder 14 is manually depressed before sample is applied to sample port 12 , then released.)
  • the first step the user performs is to turn on the meter, thereby energizing strip detector 40 , sample detector 42 , measurement system 44 , and optional heater 46 .
  • the second step is to insert the strip.
  • the strip is not transparent over at least a part of its area, so that an inserted strip will block the illumination by LED 40 a of detector 40 b .
  • the intermediate layer is formed of a nontransparent material, so that background light does not enter measurement system 44 .
  • Detector 40 b thereby senses that a strip has been inserted and triggers bladder actuator 48 to compress bladder 14 .
  • a meter display 50 then directs the user to apply a sample to sample port 12 as the third and last step the user must perform to initiate the measurement sequence.
  • the empty sample port is reflective. When a sample is introduced into the sample port, it absorbs light from LED 42 a and thereby reduces the light that is reflected to detector 42 b . That reduction in light, in turn, signals actuator 48 to release bladder 14 . The resultant suction in channel 16 draws sample through reagent area 18 to stop junction 22 . Light from LED 44 a passes through reagent area 18 , and detector 44 b .monitors the light transmitted through the sample as it is clotting. When there are multiple reagent areas, measurement system 44 includes an LED/detector pair (like 44 a and 44 b ) for each reagent area. Analysis of the transmitted light as a function of time (as described below) permits a calculation of the PT time, which is displayed on the meter display 50 . Preferably, sample temperature is maintained at about 37° C. by heater 46 .
  • FIG. 5 depicts a typical “clot signature” curve in which the current from detector 44 b is plotted as a function of time.
  • Blood is first detected in the reagent area by 44 b at time 1.
  • the blood fills the reagent area.
  • the reduction in current during that time interval is due to light scattered by red cells and is thus an approximate measure of the hematocrit.
  • sample has filled the reagent area and is at rest, its movement having been stopped by the stop junction.
  • the red cells begin to stack up like coins (rouleaux formation).
  • the rouleaux effect allows increasing light transmission through the sample (and less scattering) in the time interval between points 2 and 3.
  • clot formation ends rouleaux formation and transmission through the sample reaches a maximum.
  • the PT time can be calculated from the interval B between points 1 and 3 or between 2 and 3 .
  • blood changes state from liquid to a semi-solid gel, with a corresponding reduction in light transmission.
  • the reduction in current C between the maximum 3 and endpoint 4 correlates with fibrinogen in the sample.
  • FIG. 6 depicts a preferred embodiment of the present device. It is a multi-channel device that includes a bypass channel 52 .
  • Bypass channel 52 provides a path for sample to travel after sample has been drawn into reagent areas 118 , 218 , and 318 .
  • Sample is drawn into the bypass channel by the reduced pressure on the bladder side of stop junction 122 .
  • Reagent area 118 contains thromboplastin.
  • reagent areas 218 and 318 contain controls, more preferably, the controls described below. Area 218 contains thromboplastin, bovine eluate, and recombinant Factor VIIa.
  • the composition is selected to normalize the clotting time of a blood sample by counteracting the effect of an anticoagulant, such as warfarin.
  • Reagent area 318 contains thromboplastin and bovine eluate alone, to partially overcome the effect of an anticoagulant.
  • three measurements are made on the strip.
  • PT time of the sample the measurement of primary interest, is measured on area 118 .
  • that measurement is validated only when measurements on areas 218 and 318 yield results within a predetermined range. If either or both of these control measurements are outside the range, then a retest is indicated.
  • Extended stop junction 122 stops flow in all three reagent areas.
  • the device pictured in FIGS. 1 and 2 and described above is preferably formed by laminating thermoplastic sheets 26 and 28 to a thermoplastic intermediate layer 24 that has adhesive on both of its surfaces.
  • the cutouts that form the elements shown in FIG. 1 may be formed, for example, by laser- or die-cutting of layers 24 , 26 , and 28 .
  • the reagent area 18 on bottom layer 28 is defined by the cutout in intermediate layer 24 .
  • the bottom surface of top layer 26 , facing bottom layer 28 is hydrophobic, at least in the region of channel 16 and reagent area 18 .
  • the surface of reagent area 18 is hydrophilic.
  • the surface of sample port 12 is hydrophilic as well, to facilitate filling of the device; i.e., moving the sample from port 12 to reagent area 18 .
  • a convenient way to have hydrophilic sample and reagent areas is to have the entire surface of bottom layer 28 be hydrophilic.
  • thermoplastic films having suitably hydrophilic surfaces include 3M 9962 Antifog Film (“Antifog”), available from Medical Specialties, 3 M Health Care, St. Paul, Minn.; FMC GelBond Film, available from Bio Whittaker Molecular Applications, Rockland, Me.; polyethylene terephthalate (PET) film, whose surface has been flame-corona- or plasma-treated; ionomer film; and other conventional thermoplastic films having hydrophilic surfaces or coatings.
  • the Antifog is PET film coated with a 3M-proprietary coating and is the preferred substrate material.
  • the surface hydrophilicity can be determined in several different ways.
  • Contact angle is nominally the angle between the edge of a drop of fluid (usually purified water) that sits atop a wettable surface and the surface itself.
  • the method for measuring the contact angle has been standardized, and can be carried out using manual or automated equipment. (ASTM Test Method D5946-96, Standard Test Method for Corona-Tested Polymer Films Using Water Contact Angle Measurements.)
  • the data can generally by considered accurate and reproducible when the measured angle is greater than 25°, and films are considered quite wettable if the contact angle is about 60° or less.
  • the angles measured for Antifog were about 25°.
  • Wetting tension is measured by spreading solutions of known surface tension onto a surface to be tested and observing if the solutions “bead up.” (ASTM Test Method D2578-94, Standard Test Method for Wetting Tension of Polyethylene and Polypropylene Films). Beading up indicates that internal liquid attractive forces overcome adsorptive attraction of the surface.
  • the solutions are calibrated in units of dynes/cm, and are referred to as dyne solutions. They are commercially available in the range of 30 to 60 dynes/cm.
  • a surface is tested starting with the lowest value solution and progressing to the highest.
  • a surface is assigned the dyne/cm value corresponding to that solution that remains spread out for approximately two seconds.
  • the Antifog surface is extremely hydrophilic.
  • reagent droplets spread over the surface and, providing sufficient droplets are deposited, form a substantially uniform layer of the reagent over the desired area.
  • substantially uniform should not be construed as necessarily suggesting that the surface coating thickness is the same over the entire target area, nor even that the entire surface is coated.
  • FIG. 7 depicts a plan view of part of a typical coated target area. Note that part of the surface (A) remains uncoated, although most of the surface (B) is coated. Preferably, at least about 80% of the target area is coated. Preferably, thickness variations in the coated areas (B) are minimized; e.g., thickest region less than three times the average thickness of the coated area. Average coating thickness in coated areas is generally about 0.1 micrometer-about 1 micrometer, depending on the nature of the reagent and the particular application.
  • FIG. 8 depicts a schematic of an apparatus for nonimpact printing of reagent onto the reagent area of a substrate of the present invention.
  • Print head 60 repeatedly ejects a stream of reagent droplets onto web 62 , which moves in the direction shown by the arrow.
  • Optional masks 64 and 66 ensure that the droplet stream only reaches web 62 in reagent areas 18 .
  • mask 66 i.e., the mask closest to print head 60
  • mask 66 optionally has a hydrophobic surface 68 facing the print head.
  • Reagent from the multiple dispenser nozzles of print head 60 forms multiple reagent dots on mask surface 68 .
  • the surface is hydrophobic, the dots remain isolated and can be individually viewed by a downstream optical system 70 .
  • the hydrophilicity of surface 18 causes the droplets arriving on that surface to spread and/or coalesce, so it is more difficult for optical system 70 to detect individual dots directly on the reagent area.
  • Optical system 70 can detect and, if desired, reject defective product. For example, an absence of dots may indicate that one or more dispenser nozzles are defective.
  • suitable optical detection methods are dark field microscopy, shadowing, patterning, laser illumination, etc.
  • a colorant, or a fluorescent dye can be added to the reagent to make it more easily visible to optical system 70 .
  • methylene blue dye added to a reagent to about 0.1% final concentration, makes the reagent visible to an optical system, without substantially altering the measurements made with the reagent.
  • Print head 60 may be any nonimpact print head known in the art, including ultrasonic, electrographic, ion projection, etc.
  • print head 60 is an ink-jet print head, more preferably, a thermal ink-jet print head.
  • FIGS. 1 - 3 Two strips of the type described above for PT measurements were prepared (see FIGS. 1 - 3 ). The difference between the strips was that strip A had a bottom layer 28 of untreated polyethylene terephthalate, while strip B had a bottom layer 28 of FMC GelBond Film.
  • a blood sample was applied to each strip and PT measurements made in an apparatus of the type depicted in FIG. 4.
  • FIG. 9 depicts the resultant clotting curves.
  • the curve for strip A has a relatively flat peak (corresponding to peak 3 in FIG. 5). The flatness of the peak limits the precision of the resultant PT calculation.
  • the curve for strip B has a much sharper peak, which permits much greater precision. (Note that the PT times for the samples measured with the two strips are different.)
  • a device of this invention is made by first passing a double-sided adhesive tape (RX 675SLT, available from Scapa Tapes, Windsor, Conn.) sandwiched between two release liners into a laminating and rotary die-cutting converting system.
  • RX 675SLT double-sided adhesive tape
  • the pattern shown in FIG. 2, with the exception of the stop junction, is cut through the top release liner and tape, but not through the bottom release liner, which is then removed as waste, along with the cutouts from the tape.
  • 3M Antifog Film is laminated to the exposed bottom side of the tape.
  • Reagent thromboplastin, available from Ortho Clinical Diagnostics, Raritan, N.J.
  • Reagent is then printed onto the reagent area ( 18 ) of the film by thermal ink-jet printing, using printing heads 51612A, from Hewlett Packard, Corvallis, Oreg..
  • a sample port is cut in untreated polyester film (AR1235, available from Adhesives Research, Glen Rock, Pa.) and then laminated, in register, to the top of the double-sided tape (after removing the release layer).
  • a die then cuts the stop junction through the three layers of the sandwich.
  • Reagent that is thermal ink-jet printed onto areas 118P, 218P, and 318P is, respectively, thromboplastin; thromboplastin, bovine eluate, and recombinant Factor VIIa; and thromboplastin and bovine eluate alone.
  • the bovine eluate (plasma barium citrate bovine eluate) is available from Haemotologic Technologies, Burlington, Vt.; and recombinant Factor VIIa from American Diagnostica, Greenwich, Conn.
  • Measurements made on a whole blood sample using the strip of this Example yield a curve of the type shown in FIG. 5 for each of the reagent areas.
  • the data from the curves for the controls (reagent areas 218P and 318P) are used to qualify the data from the curve for reagent area 118P.
  • the PT time can be determined more reliably than can be done with a strip having a single reagent area.

Abstract

A medical diagnostic device has a non-absorbent substrate that has a hydrophilic target area on which a reagent is deposited by non-impact printing of microdroplets. During deposition, the device is moved relative to the stream of microdroplets to form a substantially uniform reagent layer on the substrate. The device is particularly well adapted for measuring blood coagulation times. In a preferred embodiment, coagulation times are determined by monitoring the optical transmission of light through the target area as an applied blood sample interacts with the reagent.

Description

    CROSS-REFERENCE TO PRIOR APPLICATION
  • This application is a continuation-in-part of application Ser. No. 09/333,765, filed Jun. 15, 1999.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0002]
  • This invention relates to a medical diagnostic device that is prepared by nonimpact printing; more particularly, by nonimpact printing of a reagent onto a hydrophilic surface of the device. [0003]
  • 2. Description of the Related Art [0004]
  • A variety of medical diagnostic procedures involve tests on biological fluids, such as blood, urine, or saliva, and are based on a change in a physical characteristic of such a fluid or an element of the fluid, such as blood serum. The characteristic can be an electrical, magnetic, fluidic, or optical property. When an optical property is monitored, these procedures may make use of a transparent or translucent device to contain the biological fluid and a reagent. A change in light absorption of the fluid can be related to an analyte concentration in, or property of, the fluid. Typically, a light source is located adjacent to one surface of the device and a detector is adjacent to the opposite surface. The detector measures light transmitted through a fluid sample. Alternatively, the light source and detector can be on the same side of the device, in which case the detector measures light scattered and/or reflected by the sample. Finally, a reflector may be located at or adjacent to the opposite surface. A device of this latter type, in which light is first transmitted through the sample area, then reflected through a second time, is called a “transflectance” device. References to “light” throughout this specification and the appended claims should be understood to include the infrared and ultraviolet spectra, as well as the visible. References to “absorption” are meant to refer to the reduction in intensity as a light beam passes through a medium; thus, it encompasses both “true” absorption and scattering. [0005]
  • An example of a transparent test device is described in Wells et al. W094/02850, published on Feb. 3, 1994. Their device comprises a sealed housing, which is transparent or translucent, impervious, and rigid or semi-rigid. An assay material is contained within the housing, together with one or more assay reagents at predetermined sites. The housing is opened and the sample introduced just before conducting the assay. The combination of assay reagents and analyte in the sample results in a change in optical properties, such as color, of selected reagents at the end of the assay. The results can be read visually or with an optical instrument. [0006]
  • U.S. Pat. No. 3,620,676, issued on Nov. 16, 1971 to Davis, discloses a colorimetric indicator for liquids. The indicator includes a “half-bulb cavity”, which is compressible. The bulb is compressed and released to form a suction that draws fluid from a source, through a half-tubular cavity that has an indicator imprinted on its wall. The only controls on fluid flow into the indicator are how much the bulb is compressed and how long the indicator inlet is immersed in the source, while the bulb is released. [0007]
  • U.S. Pat. 3,640,267, issued on Feb. 8, 1972 to Hurtig et al., discloses a container for collecting samples of body fluid that includes a chamber that has resilient, collapsible walls. The walls are squeezed before the container inlet is placed into the fluid being collected. When released, the walls are restored to their uncollapsed condition, drawing fluid into and through the inlet. As with the Davis device, discussed above, control of fluid flow into the indicator is very limited. [0008]
  • U.S. Pat. No. 4,088,448, issued on May 9, 1978 to Lilja et al., discloses a cuvette, which permits optical analysis of a sample mixed with a reagent. The reagent is coated on the walls of a cavity, which is then filled with a liquid sample. The sample mixes with the reagent to cause an optically-detectable change. [0009]
  • The test devices described above and in the cited references typically comprise a dry strip having a reagent coated on one or more predetermined positions. Applying these reagents to their intended positions on large numbers of these devices can, in principle, be accomplished by standard printing processes; however, nonimpact printing provides some distinct advantages. For example, nonimpact printers can be smaller, lighter, and less expensive, since they don't have to endure the repeated impact of print head on substrate. They also permit the use of transparent substrates, as required for optical devices that involve changes in light transmission. Information on the varieties of nonimpact printing appears in J. L. Johnson, [0010] Principles of Nonimpact Printing, 3d ed., Palatino Press, Irvine, Calif. 1998. (See, also, “No-splatter spray makes better wafers,” H. L. Berger, Machine Design, Feb. 5, 1998, pp. 52-55). Among the varieties of nonimpact printing, ink-jet printing has been identified as suitable for use in connection with reagent fluids.
  • British Patent Specification, 1,526,708, published on Sep. 27, 1978, discloses a reagent test device that comprises a carrier on which are printed two different substances, separated by a “predetermined interspace.” Ink-jet printing is one of the printing techniques disclosed. [0011]
  • U.S. Pat. No. 4,877,745, issued on Oct. 31, 1989, to Hayes et al., discloses a system for printing reagents onto a printing medium by propelling droplets from a jetting tube and repeating the process until a desired configuration of the reagent is printed on the medium. A piezo-electric print head was used. [0012]
  • U.S. Pat. No. 5,108,926, issued on Apr. 28, 1992, to Klebe, discloses an apparatus for precisely locating cells on a substrate by using an ink-jet printer either to deposit the cells directly onto the substrate or to deposit cell adhesion materials. The ink-jet printer used was a Hewlett-Packard Thinkjet™ printer, which is a thermal ink-jet printer (see Hewlett-Packard Journal, May, 1985). [0013]
  • U.S. Pat. No. 5,378,638, issued on Jan. 3, 1995, to Deeg et al., discloses an analysis element for the determination of an analyte in a liquid sample. The element is fabricated by ink-jet printing of reagents in a series of “compartments,” using a thermal ink-jet print head. [0014]
  • Each of the references cited above are concerned, explicitly or implicitly, with image spreading on the print medium, because the sharpness of an image is degraded to the extent that the liquid “ink” spreads across the surface before drying. For diagnostic applications, sharp “images” are typically required, because different reagents are positioned close together on a surface of a device but must not come into contact (e.g., to react) until the device is wetted by an applied sample. [0015]
  • SUMMARY OF THE INVENTION
  • The present invention provides a method for preparing a medical diagnostic reagent device, comprising the steps of [0016]
  • a) providing a non-absorbent substrate, having on its surface at least one hydrophilic target area, [0017]
  • b) providing from a nonimpact print head onto a point within the target area a pulsed stream of microdroplets of a diagnostic reagent liquid, [0018]
  • c) moving the stream relative to the substrate, and [0019]
  • d) repeating steps b) and c) at least enough times to provide a substantially uniform layer of the liquid over the target area. [0020]
  • A diagnostic reagent device of the present invention measures an analyte concentration or characteristic of a biological fluid and comprises [0021]
  • a) a sample application area for accepting a sample of the biological fluid for analysis and [0022]
  • b) a predetermined hydrophilic reagent area, onto which has been applied, by nonimpact printing, a diagnostic reagent liquid that interacts with the sample to cause in the sample a physically-measurable change that can be related to the analyte concentration or characteristic of the fluid. [0023]
  • The sample application and reagent areas may coincide or, alternatively, be spaced apart, with an intermediate path to convey the sample. The measurement is generally, but not necessarily, made when the sample is on the reagent area, and in the description below, the measurement of interest is made when the sample is in the reagent area. [0024]
  • The method is particularly well adapted for preparing a device for measuring prothrombin time (PT time), with the target area being coated with a reagent composition that catalyzes the blood clotting cascade. Similarly, the diagnostic reagent strip of the invention is particularly well adapted for measuring the PT time of a whole blood sample. [0025]
  • As used in this specification and the appended claims, the term “microdroplet” refers to droplets having a volume in the range from about 1 picoliter to 1 microliter. [0026]
  • It is surprising that the hydrophilicity of the target area provides superior results, since the hydrophilic surface would be expected to spread the reagent that is deposited, which had been thought to be undesirable.[0027]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a plan view of a device of the present invention. [0028]
  • FIG. 2 is an exploded vies of the device of FIG. 1. [0029]
  • FIG. 3 is a perspective view of the device of FIG. [0030]
  • FIG. 4 is a schematic of a meter for use with a device of this invention. [0031]
  • FIG. 5 is a graph of data that is used to determine PT time. [0032]
  • FIG. 6 is a plan view of an alternative embodiment of a device of this invention. [0033]
  • FIG. 7 is a plan view of a coating prepared by the method of the present invention. [0034]
  • FIG. 8 is a schematic of a nonimpact printing process of this invention. [0035]
  • FIG. 9 is a graph that demonstrates an advantage of the present invention.[0036]
  • DETAILED DESCRIPTION OF THE INVENTION
  • The medical diagnostic reagent device of this invention is prepared by depositing a reagent upon a hydrophilic “reagent area” of a non-absorbent substrate by a nonimpact printing process. The device is of the type that relates a physical parameter of a biological fluid, or an element of the fluid, to an analyte concentration in the fluid or to a property of the fluid. Although a variety of physical parameters—e.g., electrical, magnetic, fluidic, or optical—can form the basis for the measurement, a change in optical parameters is a preferred basis, and the details that follow refer to an optical device. A preferred embodiment of the device includes a planar substrate, such as a thermoplastic sheet. The substrate has on its surface a sample application area and the reagent area, in which the sample undergoes a change in an optical parameter, such as light scattering. The substrate, or “bottom layer,” forms with “intermediate” and “top” layers a bladder, to create a suction force to draw the sample into the device, and a stop junction, to precisely stop flow after filling the reagent area. [0037]
  • Preferably, the device is substantially transparent over the reagent area, so that the area can be illuminated by a light source on one side and the transmitted light measured on the opposite side. The nonimpact-printed reagent causes the sample to undergo a change, and the change in transmitted light is a measure of the analyte or fluid property of interest. Alternatively, light that is scattered from a fluid sample or light that passes through the sample and is reflected back through a second time (by a reflector on that opposite side) can be detected by a detector on the same side as the light source. [0038]
  • This type of device is suitable for a variety of analytical tests of biological fluids, such as determining biochemical or hematological characteristics, or measuring the concentration in such fluids of proteins, hormones, carbohydrates, lipids, drugs, toxins, gases, electrolytes, etc. The procedures for performing these tests have been described in the literature. Among the tests, and where they are described, are the following: [0039]
  • (1) Chromogenic Factor XIIa Assay (and other clotting factors as well): Rand, M. D. et al., Blood, 88, 3432 (1996). [0040]
  • (2) Factor X Assay: Bick, R. L. Disorders of Thrombosis and Hemostasis: Clinical and Laboratory Practice. Chicago, ASCP Press, 1992. [0041]
  • (3) DRVVT (Dilute Russells Viper Venom Test): Exner, T. et al., Blood Coag. Fibrinol., 1, 259 (1990). [0042]
  • (4) Immunonephelometric and Immunoturbidimetric Assays for Proteins: Whicher, J. T., CRC Crit. Rev. Clin Lab Sci. 18:213 (1983). [0043]
  • (5) TPA Assay: Mann, K. G., et al., Blood, 76, 755, (1990).; and Hartshorn, J. N. et al., Blood, 78, 833 (1991). [0044]
  • (6) APTT (Activated Partial Thromboplastin Time Assay): Proctor, R. R. and Rapaport, S. I. Amer. J. Clin. Path, 36, 212 (1961); Brandt, J. T. and Triplett, D. A. Amer. J. Clin. Path., 76, 530 (1981); and Kelsey, P. R. Thromb. Haemost. 52, 172 (1984). [0045]
  • (7) HbAlc Assay (Glycosylated Hemoglobin Assay): Nicol, D. J. et al., Clin. Chem. 29, 1694 (1983). [0046]
  • (8) Total Hemoglobin: Schneck et al., Clinical Chem., 32/33, 526 (1986); and U.S. Pat. 4,088,448. [0047]
  • (9) Factor Xa: Vinazzer, H., Proc. Symp. Dtsch. Ges. Klin. Chem., 203 (1977), ed. By Witt, I [0048]
  • (10) Colorimetric Assay for Nitric Oxide: Schmidt, H. H., et al., Biochemica, 2, 22 (1995). [0049]
  • The present device is particularly well suited for measuring blood-clotting time—“prothrombin time” or “PT time”—and details regarding such a device appear below. The modifications needed to adapt the device for applications such as those listed above require no more than routine experimentation. [0050]
  • FIG. 1 is a plan view of a [0051] device 10 of the present invention. FIG. 2 is an exploded view and FIG. 3 a perspective view of the device. Sample is applied to sample port 12 after bladder 14 has been compressed. Clearly, the region of layer 26 and/or layer 28 that adjoins the cutout for bladder 14 must be resilient, to permit bladder 14 to be compressed. Polyester of about 0.1 mm thickness has suitable resilience and springiness. Preferably, top layer 26 has a thickness of about 0.125 mm, bottom layer 28 about 0.100 mm. When the bladder is released, suction draws sample through channel 16 to reagent area 18, which contains a nonimpact-printed reagent 20. In order to ensure that reagent area 18 can be filled with sample, the volume of bladder 14 is preferably at least about equal to the combined volume of channel 16 and reagent area 18. If-reagent area 18 is to be illuminated from below, layer 28 must be transparent where it adjoins reagent area 18. For a PT test, reagent 20 contains thromboplastin that is free of bulking reagents normally found in lyophilized reagents.
  • As shown in FIGS. 1, 2, and [0052] 3, stop junction 22 adjoins bladder 14 and reagent area 18; however, a continuation of channel 16 may be on either or both sides of stop junction 22, separating the stop junction from reagent area 18 and/or bladder 14. When the sample reaches stop junction 22, sample flow stops. For PT measurements, it is important to stop the flow of sample as it reaches that point to permit reproducible “rouleaux formation”—the stacking of red blood cells—which is an important step in monitoring blood clotting using the present invention. The principle of operation of stop junctions is described in U.S. Pat. No. 5,230,866, incorporated herein by reference.
  • As shown in FIG. 2, all the above elements are formed by cutouts in [0053] intermediate layer 24, sandwiched between top layer 26 and bottom layer 28. Preferably, layer 24 is double-sided adhesive tape. Stop junction 22 is formed by an additional cutout in layer 26 and/or 28, aligned with the cutout in layer 24 and sealed with sealing layer 30 and/or 32. Preferably, as shown, the stop junction comprises cutouts in both layers 26 and 28, with sealing layers 30 and 32. Each cutout for stop junction 22 is at least as wide as channel 16. Also shown in FIG. 2 is an optional filter 12A to cover sample port 12. The filter may separate out red blood cells from a whole blood sample and/or may contain a reagent to interact with the blood to provide additional information. A suitable filter comprises an anisotropic membrane, preferably a polysulfone membrane of the type available from Spectral Diagnostics, Inc., Toronto, Canada. Optional reflector 18A may be on, or adjacent to, a surface of layer 26 and positioned over reagent area 18. If the reflector is present, the device becomes a transflectance device.
  • The method of using the strip of FIGS. 1, 2, and [0054] 3 can be understood with reference to a schematic of the elements of a meter shown in FIG. 4, which contemplates an automated meter. Alternatively, manual operation is also possible. (In that case, bladder 14 is manually depressed before sample is applied to sample port 12, then released.)
  • The first step the user performs is to turn on the meter, thereby energizing [0055] strip detector 40, sample detector 42, measurement system 44, and optional heater 46. The second step is to insert the strip. Preferably, the strip is not transparent over at least a part of its area, so that an inserted strip will block the illumination by LED 40 a of detector 40 b. (More preferably, the intermediate layer is formed of a nontransparent material, so that background light does not enter measurement system 44.) Detector 40 b thereby senses that a strip has been inserted and triggers bladder actuator 48 to compress bladder 14. A meter display 50 then directs the user to apply a sample to sample port 12 as the third and last step the user must perform to initiate the measurement sequence.
  • The empty sample port is reflective. When a sample is introduced into the sample port, it absorbs light from [0056] LED 42 a and thereby reduces the light that is reflected to detector 42 b. That reduction in light, in turn, signals actuator 48 to release bladder 14. The resultant suction in channel 16 draws sample through reagent area 18 to stop junction 22. Light from LED 44 a passes through reagent area 18, and detector 44 b.monitors the light transmitted through the sample as it is clotting. When there are multiple reagent areas, measurement system 44 includes an LED/detector pair (like 44 a and 44 b) for each reagent area. Analysis of the transmitted light as a function of time (as described below) permits a calculation of the PT time, which is displayed on the meter display 50. Preferably, sample temperature is maintained at about 37° C. by heater 46.
  • FIG. 5 depicts a typical “clot signature” curve in which the current from detector [0057] 44 b is plotted as a function of time. Blood is first detected in the reagent area by 44 b at time 1. In the time interval A, between points 1 and 2, the blood fills the reagent area. The reduction in current during that time interval is due to light scattered by red cells and is thus an approximate measure of the hematocrit. At point 2, sample has filled the reagent area and is at rest, its movement having been stopped by the stop junction. The red cells begin to stack up like coins (rouleaux formation). The rouleaux effect allows increasing light transmission through the sample (and less scattering) in the time interval between points 2 and 3. At point 3, clot formation ends rouleaux formation and transmission through the sample reaches a maximum. The PT time can be calculated from the interval B between points 1 and 3 or between 2 and 3. Thereafter, blood changes state from liquid to a semi-solid gel, with a corresponding reduction in light transmission. The reduction in current C between the maximum 3 and endpoint 4 correlates with fibrinogen in the sample.
  • FIG. 6 depicts a preferred embodiment of the present device. It is a multi-channel device that includes a [0058] bypass channel 52. Bypass channel 52 provides a path for sample to travel after sample has been drawn into reagent areas 118, 218, and 318. Sample is drawn into the bypass channel by the reduced pressure on the bladder side of stop junction 122. Sample flow stops when the ambient pressure is equalized on both sides of the stop junction. Reagent area 118 contains thromboplastin. Preferably, reagent areas 218 and 318 contain controls, more preferably, the controls described below. Area 218 contains thromboplastin, bovine eluate, and recombinant Factor VIIa. The composition is selected to normalize the clotting time of a blood sample by counteracting the effect of an anticoagulant, such as warfarin. Reagent area 318 contains thromboplastin and bovine eluate alone, to partially overcome the effect of an anticoagulant. Thus, three measurements are made on the strip. PT time of the sample, the measurement of primary interest, is measured on area 118. However, that measurement is validated only when measurements on areas 218 and 318 yield results within a predetermined range. If either or both of these control measurements are outside the range, then a retest is indicated. Extended stop junction 122 stops flow in all three reagent areas.
  • The device pictured in FIGS. 1 and 2 and described above is preferably formed by laminating [0059] thermoplastic sheets 26 and 28 to a thermoplastic intermediate layer 24 that has adhesive on both of its surfaces. The cutouts that form the elements shown in FIG. 1 may be formed, for example, by laser- or die-cutting of layers 24, 26, and 28.
  • The [0060] reagent area 18 on bottom layer 28 is defined by the cutout in intermediate layer 24. Preferably, the bottom surface of top layer 26, facing bottom layer 28, is hydrophobic, at least in the region of channel 16 and reagent area 18. The surface of reagent area 18 is hydrophilic. Preferably, the surface of sample port 12 is hydrophilic as well, to facilitate filling of the device; i.e., moving the sample from port 12 to reagent area 18. A convenient way to have hydrophilic sample and reagent areas is to have the entire surface of bottom layer 28 be hydrophilic. Commercially available thermoplastic films having suitably hydrophilic surfaces include 3M 9962 Antifog Film (“Antifog”), available from Medical Specialties, 3M Health Care, St. Paul, Minn.; FMC GelBond Film, available from Bio Whittaker Molecular Applications, Rockland, Me.; polyethylene terephthalate (PET) film, whose surface has been flame-corona- or plasma-treated; ionomer film; and other conventional thermoplastic films having hydrophilic surfaces or coatings. The Antifog is PET film coated with a 3M-proprietary coating and is the preferred substrate material.
  • In determining the suitability of a substrate for the present device and method, the surface hydrophilicity can be determined in several different ways. [0061]
  • Contact angle is nominally the angle between the edge of a drop of fluid (usually purified water) that sits atop a wettable surface and the surface itself. The method for measuring the contact angle has been standardized, and can be carried out using manual or automated equipment. (ASTM Test Method D5946-96, Standard Test Method for Corona-Tested Polymer Films Using Water Contact Angle Measurements.) The data can generally by considered accurate and reproducible when the measured angle is greater than 25°, and films are considered quite wettable if the contact angle is about 60° or less. The angles measured for Antifog were about 25°. [0062]
  • Wetting tension is measured by spreading solutions of known surface tension onto a surface to be tested and observing if the solutions “bead up.” (ASTM Test Method D2578-94, Standard Test Method for Wetting Tension of Polyethylene and Polypropylene Films). Beading up indicates that internal liquid attractive forces overcome adsorptive attraction of the surface. The solutions are calibrated in units of dynes/cm, and are referred to as dyne solutions. They are commercially available in the range of 30 to 60 dynes/cm. A surface is tested starting with the lowest value solution and progressing to the highest. A surface is assigned the dyne/cm value corresponding to that solution that remains spread out for approximately two seconds. Since Antifog wetted out all the solutions, it has been characterized as having a surface wetting tension greater than 60 dynes/cm. 3M's Medical Specialties Department has developed a wetting test to characterize water-wetting of film. (3M SMD #6122, Wetting Test, Dec. 4, 1998—available from 3M Center, St. Paul, MN 55144-1000.) The test involves careful placement of an aqueous dye solution onto a surface, drying it, and measuring the diameter of the dried spots. The data collected were generally in the 35 to 40 point range, which indicates a very wettable surface. [0063]
  • Based on the measurements described above, we conclude that the Antifog surface is extremely hydrophilic. When a surface is adequately hydrophilic, then reagent droplets spread over the surface and, providing sufficient droplets are deposited, form a substantially uniform layer of the reagent over the desired area. As used in this specification and the appended claims, the term “substantially uniform” should not be construed as necessarily suggesting that the surface coating thickness is the same over the entire target area, nor even that the entire surface is coated. [0064]
  • FIG. 7 depicts a plan view of part of a typical coated target area. Note that part of the surface (A) remains uncoated, although most of the surface (B) is coated. Preferably, at least about 80% of the target area is coated. Preferably, thickness variations in the coated areas (B) are minimized; e.g., thickest region less than three times the average thickness of the coated area. Average coating thickness in coated areas is generally about 0.1 micrometer-about 1 micrometer, depending on the nature of the reagent and the particular application. [0065]
  • FIG. 8 depicts a schematic of an apparatus for nonimpact printing of reagent onto the reagent area of a substrate of the present invention. [0066] Print head 60 repeatedly ejects a stream of reagent droplets onto web 62, which moves in the direction shown by the arrow. Optional masks 64 and 66 ensure that the droplet stream only reaches web 62 in reagent areas 18.
  • To control the printing, [0067] mask 66; i.e., the mask closest to print head 60, optionally has a hydrophobic surface 68 facing the print head. Reagent from the multiple dispenser nozzles of print head 60 forms multiple reagent dots on mask surface 68. Because the surface is hydrophobic, the dots remain isolated and can be individually viewed by a downstream optical system 70. The hydrophilicity of surface 18 causes the droplets arriving on that surface to spread and/or coalesce, so it is more difficult for optical system 70 to detect individual dots directly on the reagent area.
  • [0068] Optical system 70 can detect and, if desired, reject defective product. For example, an absence of dots may indicate that one or more dispenser nozzles are defective. Among the suitable optical detection methods are dark field microscopy, shadowing, patterning, laser illumination, etc. Optionally, a colorant, or a fluorescent dye, can be added to the reagent to make it more easily visible to optical system 70. For example, methylene blue dye, added to a reagent to about 0.1% final concentration, makes the reagent visible to an optical system, without substantially altering the measurements made with the reagent.
  • [0069] Print head 60 may be any nonimpact print head known in the art, including ultrasonic, electrographic, ion projection, etc. Preferably, print head 60 is an ink-jet print head, more preferably, a thermal ink-jet print head.
  • The following examples demonstrate the present invention in its various embodiments, but are not intended to be in any way limiting. [0070]
  • EXAMPLE 1 (COMPARATIVE EXAMPLE)
  • Two strips of the type described above for PT measurements were prepared (see FIGS. [0071] 1-3). The difference between the strips was that strip A had a bottom layer 28 of untreated polyethylene terephthalate, while strip B had a bottom layer 28 of FMC GelBond Film. A blood sample was applied to each strip and PT measurements made in an apparatus of the type depicted in FIG. 4. FIG. 9 depicts the resultant clotting curves. The curve for strip A has a relatively flat peak (corresponding to peak 3 in FIG. 5). The flatness of the peak limits the precision of the resultant PT calculation. By contrast, the curve for strip B has a much sharper peak, which permits much greater precision. (Note that the PT times for the samples measured with the two strips are different.)
  • EXAMPLE 2
  • A device of this invention is made by first passing a double-sided adhesive tape (RX 675SLT, available from Scapa Tapes, Windsor, Conn.) sandwiched between two release liners into a laminating and rotary die-cutting converting system. The pattern shown in FIG. 2, with the exception of the stop junction, is cut through the top release liner and tape, but not through the bottom release liner, which is then removed as waste, along with the cutouts from the tape. 3M Antifog Film is laminated to the exposed bottom side of the tape. Reagent (thromboplastin, available from Ortho Clinical Diagnostics, Raritan, N.J.) is then printed onto the reagent area ([0072] 18) of the film by thermal ink-jet printing, using printing heads 51612A, from Hewlett Packard, Corvallis, Oreg.. A sample port is cut in untreated polyester film (AR1235, available from Adhesives Research, Glen Rock, Pa.) and then laminated, in register, to the top of the double-sided tape (after removing the release layer). A die then cuts the stop junction through the three layers of the sandwich. Finally, strips of single-sided adhesive tape—Catalog No. 9843 (MSX4841), available from 3M, St. Paul, Minn.—are applied to the outside of the polyester layers to seal the stop junction.
  • EXAMPLE 3
  • A procedure that is similar to the one described in Example 1 is followed to make a strip of the type depicted in FIG. 6. Reagent that is thermal ink-jet printed onto areas 118P, 218P, and 318P is, respectively, thromboplastin; thromboplastin, bovine eluate, and recombinant Factor VIIa; and thromboplastin and bovine eluate alone. The bovine eluate (plasma barium citrate bovine eluate) is available from Haemotologic Technologies, Burlington, Vt.; and recombinant Factor VIIa from American Diagnostica, Greenwich, Conn. [0073]
  • Measurements made on a whole blood sample using the strip of this Example yield a curve of the type shown in FIG. 5 for each of the reagent areas. The data from the curves for the controls (reagent areas 218P and 318P) are used to qualify the data from the curve for reagent area 118P. As a result, the PT time can be determined more reliably than can be done with a strip having a single reagent area. [0074]

Claims (20)

We claim:
1. A method for preparing a medical diagnostic reagent device, comprising the steps of
a) providing a non-absorbent substrate, having on its surface at least one hydrophilic target area,
b) providing from a nonimpact print head onto a point within the target area a pulsed stream of microdroplets of a diagnostic reagent liquid.
c) moving the stream relative to the substrate, and
d) repeating steps b) and c) at least enough times to provide a substantially uniform layer of the liquid over the target area.
2. The method of claim 1, in which the substrate comprises a substantially planar sheet.
3. The method of claim 1, in which the substrate comprises a thermoplastic sheet.
4. The method of claim 1, in which each of the at least one target areas has a water contact angle of no more than about 60°.
5. The method of claim 1, in which the print head is a thermal ink-jet print head.
6. The method of claim 1, in which the reagent liquid comprises thromboplastin.
7. The method of claim 2, in which the stream travels in a direction that is substantially perpendicular to the substrate, and the stream is moved relative to the substrate by moving the substrate in a direction that is substantially perpendicular to the direction of stream travel.
8. The method of claim 1, in which the stream passes through a hole in a sheet that is positioned between the dispenser and substrate.
9. The method of claim 8, in which the sheet has a hydrophobic surface that faces the dispenser.
10. The method of claim 9, in which the reagent comprises a colorant.
11. A diagnostic reagent device for measuring an analyte concentration or characteristic of a biological fluid, including a non-absorbent substrate comprising
a) a sample application area for accepting a sample of the biological fluid for analysis and
b) a predetermined hydrophilic reagent area, onto which has been applied, by nonimpact printing, a diagnostic reagent liquid that interacts with the sample to cause in the sample a physically-measurable change that can be related to the analyte concentration or characteristic of the fluid.
12. The device of claim 11, in which the sample application area and reagent area substantially coincide.
13. The device of claim 11, further comprising means for conveying the sample from the application area to the reagent area.
14. The device of claim 11, in which the sample application area is hydrophilic.
15. The device of claim 11, in which the substrate comprises a substantially transparent planar sheet.
16. The device of claim 11, in which the substrate comprises a substantially transparent thermoplastic sheet.
17. The device of claim 11, in which the reagent liquid comprises thromboplastin.
18. The device of claim 11, in which the reagent liquid comprises a colorant.
19. The device of claim 13, in which the means for conveying the sample from the application area to the reagent area comprises a top layer, separated from the substrate by an intermediate layer that has a through hole and adjoining channel cut into it, the top layer, intermediate layer, and substrate forming a bladder that, when compressed, and released causes in the channel a reduced pressure that draws blood into the reagent area.
20. The device of claim 19, in which the top layer has a hydrophobic surface facing the substrate, at least in the channel and reagent area.
US10/061,723 1998-07-20 2002-02-01 Microdroplet dispensing for a medical diagnostic device Abandoned US20020098114A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/061,723 US20020098114A1 (en) 1998-07-20 2002-02-01 Microdroplet dispensing for a medical diagnostic device

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9342198P 1998-07-20 1998-07-20
US09/333,765 US6521182B1 (en) 1998-07-20 1999-06-15 Fluidic device for medical diagnostics
US09/454,196 US6830934B1 (en) 1999-06-15 1999-12-03 Microdroplet dispensing for a medical diagnostic device
US10/061,723 US20020098114A1 (en) 1998-07-20 2002-02-01 Microdroplet dispensing for a medical diagnostic device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/454,196 Continuation US6830934B1 (en) 1998-07-20 1999-12-03 Microdroplet dispensing for a medical diagnostic device

Publications (1)

Publication Number Publication Date
US20020098114A1 true US20020098114A1 (en) 2002-07-25

Family

ID=23803682

Family Applications (3)

Application Number Title Priority Date Filing Date
US09/454,196 Expired - Lifetime US6830934B1 (en) 1998-07-20 1999-12-03 Microdroplet dispensing for a medical diagnostic device
US10/061,723 Abandoned US20020098114A1 (en) 1998-07-20 2002-02-01 Microdroplet dispensing for a medical diagnostic device
US10/461,219 Abandoned US20030210287A1 (en) 1998-07-20 2003-06-13 Microdroplet dispensing methods for a medical diagnostic device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/454,196 Expired - Lifetime US6830934B1 (en) 1998-07-20 1999-12-03 Microdroplet dispensing for a medical diagnostic device

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/461,219 Abandoned US20030210287A1 (en) 1998-07-20 2003-06-13 Microdroplet dispensing methods for a medical diagnostic device

Country Status (21)

Country Link
US (3) US6830934B1 (en)
EP (1) EP1107004B1 (en)
JP (1) JP2001201504A (en)
KR (1) KR20010062005A (en)
CN (1) CN1213302C (en)
AR (1) AR026703A1 (en)
AT (1) ATE325342T1 (en)
AU (1) AU775559B2 (en)
BR (1) BR0005697A (en)
CA (1) CA2327305A1 (en)
DE (1) DE60027677T2 (en)
DK (1) DK1107004T3 (en)
ES (1) ES2264921T3 (en)
HK (2) HK1036838A1 (en)
IL (1) IL139789A (en)
MX (1) MXPA00011830A (en)
NO (1) NO320095B1 (en)
PT (1) PT1107004E (en)
RU (1) RU2256167C2 (en)
SG (1) SG89361A1 (en)
TW (1) TW539546B (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064480A1 (en) * 1998-07-20 2002-05-30 Shartle Robert Justice Fluidic device for medical diagnostics
US20030210287A1 (en) * 1998-07-20 2003-11-13 Harding Ian A. Microdroplet dispensing methods for a medical diagnostic device
US6673617B2 (en) * 2002-03-14 2004-01-06 Lifescan, Inc. Test strip qualification system
US6682933B2 (en) * 2002-03-14 2004-01-27 Lifescan, Inc. Test strip qualification system
US20060057740A1 (en) * 2002-12-02 2006-03-16 Arkray Method for manufacturing tool for analysis
EP2056653A1 (en) * 2006-08-23 2009-05-06 Kondoh Industries Ltd. Soft x-ray shielding sheet used in soft x-ray electrostatic removal device and its manufacturing method
US20130341265A1 (en) * 2010-11-10 2013-12-26 Boehringer Ingelheim Microparts Gmbh Device for filtering blood
US20160067709A1 (en) * 2014-09-05 2016-03-10 Htc Corporation Micro-channel module
US20160089671A1 (en) * 2014-09-26 2016-03-31 Picosys Incorporated, a corporation of the State of California DBA Invenios Method and apparatus for taped interlayer flow cell with masking and conductive traces
CN105899935A (en) * 2013-01-07 2016-08-24 安盛生科股份有限公司 Test strips and method for reading test strips
US9466104B2 (en) 2012-04-06 2016-10-11 Ixensor Inc. Reading test strip with multiple reaction areas under different exposures or light intensities
US20170210344A1 (en) * 2014-07-24 2017-07-27 Robert Bosch Gmbh Windscreen wiper device
US9778200B2 (en) 2012-12-18 2017-10-03 Ixensor Co., Ltd. Method and apparatus for analyte measurement
US20180353955A1 (en) * 2017-06-08 2018-12-13 Integra Biosciences Ag Sample and reagent reservoir kits and liners with anti-vacuum feature
WO2019141876A1 (en) * 2018-01-22 2019-07-25 Q-Linea Ab Sample holder
US20210164015A1 (en) * 2018-08-17 2021-06-03 Becton, Dickinson And Company Antimicrobial susceptibility testing using microdroplets
CN114624453A (en) * 2022-05-11 2022-06-14 深圳市帝迈生物技术有限公司 Sample analyzer for coagulation and immunity joint detection and detection method thereof

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
EP1323465A1 (en) 2001-12-31 2003-07-02 Corning Incorporated Flexible high density array print head with systems and methods for aligning pin plate, reservoir and substrate with respect to each other
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
ATE476137T1 (en) 2003-05-30 2010-08-15 Pelikan Technologies Inc METHOD AND DEVICE FOR INJECTING LIQUID
WO2004107964A2 (en) 2003-06-06 2004-12-16 Pelikan Technologies, Inc. Blood harvesting device with electronic control
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
WO2005098431A1 (en) * 2004-03-05 2005-10-20 Egomedical Swiss Ag Analyte test system for determining the concentration of an analyte in a physiological fluid
GB0405999D0 (en) * 2004-03-17 2004-04-21 Cozart Bioscience Ltd Procedure for manufacture of strips for lateral flow immunochromatographic devices
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
JP2006053090A (en) * 2004-08-13 2006-02-23 Alps Electric Co Ltd Inspection plate and inspection method using it
AU2004322161B2 (en) 2004-08-13 2009-12-03 Egomedical Technologies Ag Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
JPWO2006095615A1 (en) * 2005-03-07 2008-08-14 株式会社クラレ Microchannel array and manufacturing method, and blood measurement method using the same
GB2426334A (en) * 2005-05-20 2006-11-22 Orion Diagnostica Oy Application of a reagent to a matrix material
US8263414B2 (en) 2005-05-23 2012-09-11 Siemens Healthcare Diagnostics Inc. Dispensing of a diagnostic liquid onto a diagnostic reagent
US8016154B2 (en) * 2005-05-25 2011-09-13 Lifescan, Inc. Sensor dispenser device and method of use
US8192599B2 (en) * 2005-05-25 2012-06-05 Universal Biosensors Pty Ltd Method and apparatus for electrochemical analysis
US8323464B2 (en) * 2005-05-25 2012-12-04 Universal Biosensors Pty Ltd Method and apparatus for electrochemical analysis
CA2614771A1 (en) * 2005-08-31 2007-03-08 Egomedical Technologies Ag Analyte test system using non-enzymatic analyte recognition elements
JP2009506332A (en) * 2005-08-31 2009-02-12 エゴメディカル テクノロジーズ アクチエンゲゼルシャフト Coagulation inspection system
US7749371B2 (en) 2005-09-30 2010-07-06 Lifescan, Inc. Method and apparatus for rapid electrochemical analysis
US8529751B2 (en) 2006-03-31 2013-09-10 Lifescan, Inc. Systems and methods for discriminating control solution from a physiological sample
US7837941B2 (en) * 2006-04-07 2010-11-23 Agamatrix, Inc. Method and apparatus for monitoring alteration of flow characteristics in a liquid sample
GB0617035D0 (en) * 2006-08-30 2006-10-11 Inverness Medical Switzerland Fluidic indicator device
WO2008071218A1 (en) * 2006-12-14 2008-06-19 Egomedical Swiss Ag Monitoring device
WO2008092470A1 (en) * 2007-01-29 2008-08-07 Egomedical Swiss Ag Resealeable container for storing moisture sensitive test elements
MX2009013093A (en) * 2007-06-20 2010-05-17 Mec Dynamics Corp Methods and apparatus for measuring blood coagulation.
EP2040073A1 (en) * 2007-09-20 2009-03-25 Iline Microsystems, S.L. Microfluidic device and method for fluid clotting time determination
US8778168B2 (en) 2007-09-28 2014-07-15 Lifescan, Inc. Systems and methods of discriminating control solution from a physiological sample
US8001825B2 (en) * 2007-11-30 2011-08-23 Lifescan, Inc. Auto-calibrating metering system and method of use
US8603768B2 (en) 2008-01-17 2013-12-10 Lifescan, Inc. System and method for measuring an analyte in a sample
EP2254699A1 (en) * 2008-03-11 2010-12-01 Koninklijke Philips Electronics N.V. Filtering apparatus for filtering a fluid
EP2265324B1 (en) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
US8551320B2 (en) 2008-06-09 2013-10-08 Lifescan, Inc. System and method for measuring an analyte in a sample
EP2166352A1 (en) * 2008-09-17 2010-03-24 F.Hoffmann-La Roche Ag Device and method for determining an analyte in a fluid sample
US9149646B2 (en) * 2008-12-31 2015-10-06 Koninklijke Philips N.V. Method and apparatus for controlling a process of injury therapy
KR100909342B1 (en) * 2009-01-22 2009-07-23 박효남 Apparatus for minutely regulating liquid medicine
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8101065B2 (en) 2009-12-30 2012-01-24 Lifescan, Inc. Systems, devices, and methods for improving accuracy of biosensors using fill time
US8877034B2 (en) * 2009-12-30 2014-11-04 Lifescan, Inc. Systems, devices, and methods for measuring whole blood hematocrit based on initial fill velocity
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
ES2478255T3 (en) 2010-08-02 2014-07-21 Cilag Gmbh International System and methods for higher pressure for temperature correction of glucose results for control solution
US8932445B2 (en) 2010-09-30 2015-01-13 Cilag Gmbh International Systems and methods for improved stability of electrochemical sensors
US8617370B2 (en) 2010-09-30 2013-12-31 Cilag Gmbh International Systems and methods of discriminating between a control sample and a test fluid using capacitance
US8956518B2 (en) 2011-04-20 2015-02-17 Lifescan, Inc. Electrochemical sensors with carrier field
WO2013109549A2 (en) 2012-01-16 2013-07-25 Abram Scientific, Inc. Methods, devices, and systems for measuring physical properties of fluid
US9063121B2 (en) 2012-05-09 2015-06-23 Stat-Diagnostica & Innovation, S.L. Plurality of reaction chambers in a test cartridge
EP2696193A1 (en) * 2012-08-06 2014-02-12 Andrew Wheeler Assay detection systems and methods
BR112015005055A2 (en) 2012-09-07 2017-07-04 Cilag Gmbh Int electrochemical sensors and method for their manufacture
GB201223079D0 (en) * 2012-12-20 2013-02-06 Sepsis Ltd Point of care sepsis assay device and method
US8926369B2 (en) 2012-12-20 2015-01-06 Lifescan Scotland Limited Electrical connector for substrate having conductive tracks
US9341639B2 (en) 2013-07-26 2016-05-17 Industrial Technology Research Institute Apparatus for microfluid detection
US20150072365A1 (en) 2013-09-10 2015-03-12 Cilag Gmbh International Magnetically aligning test strips in test meter
US9291593B2 (en) 2013-11-22 2016-03-22 Cilag Gmbh International Dual-chamber analytical test strip
US20150176049A1 (en) 2013-12-23 2015-06-25 Cilag Gmbh International Determining usability of analytical test strip
CA2946877C (en) * 2014-04-30 2021-02-09 Instrumentation Laboratory Company Methods and systems for point-of-care coagulation assays by optical detection
WO2016010748A1 (en) 2014-07-14 2016-01-21 Li-Cor, Inc. Analyte separator with electrohydrodynamic taylor cone jet blotter
US9586399B2 (en) 2015-03-30 2017-03-07 Funai Electric Co., Ltd. Fluid ejection device for depositing a discrete quantity of fluid onto a surface
US9377457B1 (en) * 2015-10-19 2016-06-28 Naishu Wang Progressive compression driven flow cartridge for analyte detecting strip and method
WO2017136284A1 (en) * 2016-02-01 2017-08-10 Li-Cor, Inc. Capillary electrophoresis inkjet dispensing
CA3031226A1 (en) 2016-08-08 2018-02-15 Li-Cor, Inc. Multi-sheath flow and on-chip terminating electrode for microfluidic direct-blotting
US11241689B2 (en) 2016-08-08 2022-02-08 Li-Cor, Inc. Microchip electrophoresis inkjet dispensing
US10928289B2 (en) * 2017-05-04 2021-02-23 University Of Connecticut Assembly for measuring the viscosity of fluids using microchannels
CN108956543B (en) * 2017-05-18 2021-02-26 微采视像科技股份有限公司 Method for measuring prothrombin time
GB2599162A (en) * 2020-09-29 2022-03-30 Ffei Ltd Cell deposition and imaging apparatus

Citations (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3620676A (en) * 1969-02-20 1971-11-16 Sterilizer Control Royalties A Disposable colorimetric indicator and sampling device for liquids
US3640267A (en) * 1969-12-15 1972-02-08 Damon Corp Clinical sample container
US4088448A (en) * 1975-09-29 1978-05-09 Lilja Jan Evert Apparatus for sampling, mixing the sample with a reagent and making particularly optical analyses
US4420566A (en) * 1982-06-10 1983-12-13 Eastman Kodak Company Method and apparatus for detecting sample fluid on an analysis slide
US4426451A (en) * 1981-01-28 1984-01-17 Eastman Kodak Company Multi-zoned reaction vessel having pressure-actuatable control means between zones
US4756884A (en) * 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
US4761381A (en) * 1985-09-18 1988-08-02 Miles Inc. Volume metering capillary gap device for applying a liquid sample onto a reactive surface
US4822568A (en) * 1986-03-28 1989-04-18 Minoru Tomita Apparatus for measuring aggregation rate of whole blood red blood cells
US4847209A (en) * 1987-11-09 1989-07-11 Miles Inc. Latex agglutination immunoassay in the presence of hemoglobin
US4849340A (en) * 1987-04-03 1989-07-18 Cardiovascular Diagnostics, Inc. Reaction system element and method for performing prothrombin time assay
US4868129A (en) * 1987-08-27 1989-09-19 Biotrack Inc. Apparatus and method for dilution and mixing of liquid samples
US4877745A (en) * 1986-11-17 1989-10-31 Abbott Laboratories Apparatus and process for reagent fluid dispensing and printing
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5049487A (en) * 1986-08-13 1991-09-17 Lifescan, Inc. Automated initiation of timing of reflectance readings
US5068181A (en) * 1989-12-01 1991-11-26 Akzo N.V. Method of monitoring reagent delivery in a scanning spectrophotometer
US5100620A (en) * 1989-05-15 1992-03-31 Miles, Inc. Capillary tube/gap reagent format
US5104813A (en) * 1989-04-13 1992-04-14 Biotrack, Inc. Dilution and mixing cartridge
US5108926A (en) * 1987-09-08 1992-04-28 Board Of Regents, The University Of Texas System Apparatus for the precise positioning of cells
US5196926A (en) * 1990-05-19 1993-03-23 Goldstar Co., Ltd. Optical system for an lcd projector
US5208163A (en) * 1990-08-06 1993-05-04 Miles Inc. Self-metering fluid analysis device
US5230866A (en) * 1991-03-01 1993-07-27 Biotrack, Inc. Capillary stop-flow junction having improved stability against accidental fluid flow
US5242606A (en) * 1990-06-04 1993-09-07 Abaxis, Incorporated Sample metering port for analytical rotor having overflow chamber
US5338688A (en) * 1990-08-02 1994-08-16 Boehringer Mannheim Gmbh Method for the metered application of a biochemical analytical liquid to a target
US5366902A (en) * 1990-10-30 1994-11-22 Hypoguard (Uk) Limited Collection and display device
US5378638A (en) * 1990-08-02 1995-01-03 Boehringer Mannheim Gmbh Analysis element and process for its manufacture
US5472603A (en) * 1992-04-02 1995-12-05 Abaxis, Inc. Analytical rotor with dye mixing chamber
US5504011A (en) * 1994-10-21 1996-04-02 International Technidyne Corporation Portable test apparatus and associated method of performing a blood coagulation test
US5508521A (en) * 1994-12-05 1996-04-16 Cardiovascular Diagnostics Inc. Method and apparatus for detecting liquid presence on a reflecting surface using modulated light
US5610287A (en) * 1993-12-06 1997-03-11 Molecular Tool, Inc. Method for immobilizing nucleic acid molecules
US5627041A (en) * 1994-09-02 1997-05-06 Biometric Imaging, Inc. Disposable cartridge for an assay of a biological sample
US5628961A (en) * 1993-10-28 1997-05-13 I-Stat Corporation Apparatus for assaying viscosity changes in fluid samples and method of conducting same
US5674699A (en) * 1993-06-08 1997-10-07 Chronomed, Inc. Two-phase optical assay
US5677195A (en) * 1991-11-22 1997-10-14 Affymax Technologies N.V. Combinatorial strategies for polymer synthesis
US5700695A (en) * 1994-06-30 1997-12-23 Zia Yassinzadeh Sample collection and manipulation method
US5708278A (en) * 1996-05-13 1998-01-13 Johnson & Johnson Clinical Diagnostics, Inc. Reflective wetness detector
US5728352A (en) * 1994-11-14 1998-03-17 Advanced Care Products Disposable electronic diagnostic instrument
US5736404A (en) * 1995-12-27 1998-04-07 Zia Yassinzadeh Flow detection appartus and method
US5827681A (en) * 1996-12-20 1998-10-27 University Technology Corporation Rapid detection and drug sensitivity of malaria
US5847209A (en) * 1997-12-03 1998-12-08 Gupta; Anurag Ateet Process for recovery of solid and reusable urea from the urea adduction process
US6001307A (en) * 1996-04-26 1999-12-14 Kyoto Daiichi Kagaku Co., Ltd. Device for analyzing a sample
US6033866A (en) * 1997-12-08 2000-03-07 Biomedix, Inc. Highly sensitive amperometric bi-mediator-based glucose biosensor
US6066448A (en) * 1995-03-10 2000-05-23 Meso Sclae Technologies, Llc. Multi-array, multi-specific electrochemiluminescence testing
US6066504A (en) * 1997-06-27 2000-05-23 Hemosense, Inc. Coagulation or lysis assays using an electroactive species
US6084660A (en) * 1998-07-20 2000-07-04 Lifescan, Inc. Initiation of an analytical measurement in blood
US6207369B1 (en) * 1995-03-10 2001-03-27 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
US6261519B1 (en) * 1998-07-20 2001-07-17 Lifescan, Inc. Medical diagnostic device with enough-sample indicator
US6362890B1 (en) * 1999-06-14 2002-03-26 Roche Diagnostics Gmbh Method and device for checking the liquid take up of a test layer of an analysis element
US20020064480A1 (en) * 1998-07-20 2002-05-30 Shartle Robert Justice Fluidic device for medical diagnostics
US6640267B1 (en) * 1999-09-27 2003-10-28 Cypress Semiconductor Corp. Architecture for multi-queue storage element
US20030210287A1 (en) * 1998-07-20 2003-11-13 Harding Ian A. Microdroplet dispensing methods for a medical diagnostic device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US567715A (en) * 1896-09-15 William houghton
IL52322A (en) 1976-06-18 1980-10-26 Alfa Laval Ab Method of making reagent test device and device made accorording to this method
US5039617A (en) * 1989-04-20 1991-08-13 Biotrack, Inc. Capillary flow device and method for measuring activated partial thromboplastin time
AU4681493A (en) 1992-07-21 1994-02-14 Medix Biotech, Inc. Transparent assay test devices and methods
US5478751A (en) * 1993-12-29 1995-12-26 Abbott Laboratories Self-venting immunodiagnositic devices and methods of performing assays
US6991762B1 (en) * 1996-04-26 2006-01-31 Arkray, Inc. Device for analyzing a sample

Patent Citations (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3620676A (en) * 1969-02-20 1971-11-16 Sterilizer Control Royalties A Disposable colorimetric indicator and sampling device for liquids
US3640267A (en) * 1969-12-15 1972-02-08 Damon Corp Clinical sample container
US4088448A (en) * 1975-09-29 1978-05-09 Lilja Jan Evert Apparatus for sampling, mixing the sample with a reagent and making particularly optical analyses
US4426451A (en) * 1981-01-28 1984-01-17 Eastman Kodak Company Multi-zoned reaction vessel having pressure-actuatable control means between zones
US4420566A (en) * 1982-06-10 1983-12-13 Eastman Kodak Company Method and apparatus for detecting sample fluid on an analysis slide
US4756884A (en) * 1985-08-05 1988-07-12 Biotrack, Inc. Capillary flow device
US4761381A (en) * 1985-09-18 1988-08-02 Miles Inc. Volume metering capillary gap device for applying a liquid sample onto a reactive surface
US4822568A (en) * 1986-03-28 1989-04-18 Minoru Tomita Apparatus for measuring aggregation rate of whole blood red blood cells
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5049487A (en) * 1986-08-13 1991-09-17 Lifescan, Inc. Automated initiation of timing of reflectance readings
US4877745A (en) * 1986-11-17 1989-10-31 Abbott Laboratories Apparatus and process for reagent fluid dispensing and printing
US4849340A (en) * 1987-04-03 1989-07-18 Cardiovascular Diagnostics, Inc. Reaction system element and method for performing prothrombin time assay
US4868129A (en) * 1987-08-27 1989-09-19 Biotrack Inc. Apparatus and method for dilution and mixing of liquid samples
US5108926A (en) * 1987-09-08 1992-04-28 Board Of Regents, The University Of Texas System Apparatus for the precise positioning of cells
US4847209A (en) * 1987-11-09 1989-07-11 Miles Inc. Latex agglutination immunoassay in the presence of hemoglobin
US5104813A (en) * 1989-04-13 1992-04-14 Biotrack, Inc. Dilution and mixing cartridge
US5100620A (en) * 1989-05-15 1992-03-31 Miles, Inc. Capillary tube/gap reagent format
US5068181A (en) * 1989-12-01 1991-11-26 Akzo N.V. Method of monitoring reagent delivery in a scanning spectrophotometer
US5196926A (en) * 1990-05-19 1993-03-23 Goldstar Co., Ltd. Optical system for an lcd projector
US5242606A (en) * 1990-06-04 1993-09-07 Abaxis, Incorporated Sample metering port for analytical rotor having overflow chamber
US5378638A (en) * 1990-08-02 1995-01-03 Boehringer Mannheim Gmbh Analysis element and process for its manufacture
US5338688A (en) * 1990-08-02 1994-08-16 Boehringer Mannheim Gmbh Method for the metered application of a biochemical analytical liquid to a target
US5208163A (en) * 1990-08-06 1993-05-04 Miles Inc. Self-metering fluid analysis device
US5366902A (en) * 1990-10-30 1994-11-22 Hypoguard (Uk) Limited Collection and display device
US5230866A (en) * 1991-03-01 1993-07-27 Biotrack, Inc. Capillary stop-flow junction having improved stability against accidental fluid flow
US5677195A (en) * 1991-11-22 1997-10-14 Affymax Technologies N.V. Combinatorial strategies for polymer synthesis
US5472603A (en) * 1992-04-02 1995-12-05 Abaxis, Inc. Analytical rotor with dye mixing chamber
US5674699A (en) * 1993-06-08 1997-10-07 Chronomed, Inc. Two-phase optical assay
US5628961A (en) * 1993-10-28 1997-05-13 I-Stat Corporation Apparatus for assaying viscosity changes in fluid samples and method of conducting same
US5610287A (en) * 1993-12-06 1997-03-11 Molecular Tool, Inc. Method for immobilizing nucleic acid molecules
US5700695A (en) * 1994-06-30 1997-12-23 Zia Yassinzadeh Sample collection and manipulation method
US5627041A (en) * 1994-09-02 1997-05-06 Biometric Imaging, Inc. Disposable cartridge for an assay of a biological sample
US5591403A (en) * 1994-10-21 1997-01-07 International Technidyne Corporation Portable prothrombin time test apparatus and associated method of performing a prothrombin time test
US5504011A (en) * 1994-10-21 1996-04-02 International Technidyne Corporation Portable test apparatus and associated method of performing a blood coagulation test
US5728352A (en) * 1994-11-14 1998-03-17 Advanced Care Products Disposable electronic diagnostic instrument
US5508521A (en) * 1994-12-05 1996-04-16 Cardiovascular Diagnostics Inc. Method and apparatus for detecting liquid presence on a reflecting surface using modulated light
US6207369B1 (en) * 1995-03-10 2001-03-27 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
US6066448A (en) * 1995-03-10 2000-05-23 Meso Sclae Technologies, Llc. Multi-array, multi-specific electrochemiluminescence testing
US6103196A (en) * 1995-12-27 2000-08-15 Yassinzadeh; Zia Flow detection apparatus and method
US5736404A (en) * 1995-12-27 1998-04-07 Zia Yassinzadeh Flow detection appartus and method
US6001307A (en) * 1996-04-26 1999-12-14 Kyoto Daiichi Kagaku Co., Ltd. Device for analyzing a sample
US6180062B1 (en) * 1996-04-26 2001-01-30 Kyoto Daiichi Kagaku Co., Ltd. Device for analyzing a sample
US5708278A (en) * 1996-05-13 1998-01-13 Johnson & Johnson Clinical Diagnostics, Inc. Reflective wetness detector
US5827681A (en) * 1996-12-20 1998-10-27 University Technology Corporation Rapid detection and drug sensitivity of malaria
US6066504A (en) * 1997-06-27 2000-05-23 Hemosense, Inc. Coagulation or lysis assays using an electroactive species
US5847209A (en) * 1997-12-03 1998-12-08 Gupta; Anurag Ateet Process for recovery of solid and reusable urea from the urea adduction process
US6033866A (en) * 1997-12-08 2000-03-07 Biomedix, Inc. Highly sensitive amperometric bi-mediator-based glucose biosensor
US6084660A (en) * 1998-07-20 2000-07-04 Lifescan, Inc. Initiation of an analytical measurement in blood
US6261519B1 (en) * 1998-07-20 2001-07-17 Lifescan, Inc. Medical diagnostic device with enough-sample indicator
US20020064480A1 (en) * 1998-07-20 2002-05-30 Shartle Robert Justice Fluidic device for medical diagnostics
US20020110486A1 (en) * 1998-07-20 2002-08-15 Shartle Robert Justice Analyte test strip with two controls
US20030031594A1 (en) * 1998-07-20 2003-02-13 Shartle Robert Justice Vacuum loaded test strip with stop junction and bypass channel
US6521182B1 (en) * 1998-07-20 2003-02-18 Lifescan, Inc. Fluidic device for medical diagnostics
US20030156984A1 (en) * 1998-07-20 2003-08-21 John Lemke Fluidic device for medical diagnostics
US20030156983A1 (en) * 1998-07-20 2003-08-21 Shartle Robert Justice Fluidic device for medical diagnostics
US20030210287A1 (en) * 1998-07-20 2003-11-13 Harding Ian A. Microdroplet dispensing methods for a medical diagnostic device
US6362890B1 (en) * 1999-06-14 2002-03-26 Roche Diagnostics Gmbh Method and device for checking the liquid take up of a test layer of an analysis element
US6640267B1 (en) * 1999-09-27 2003-10-28 Cypress Semiconductor Corp. Architecture for multi-queue storage element

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064480A1 (en) * 1998-07-20 2002-05-30 Shartle Robert Justice Fluidic device for medical diagnostics
US20020110922A1 (en) * 1998-07-20 2002-08-15 Shartle Robert Justice Vacuum loaded test strip and method of use
US20020110486A1 (en) * 1998-07-20 2002-08-15 Shartle Robert Justice Analyte test strip with two controls
US20030156984A1 (en) * 1998-07-20 2003-08-21 John Lemke Fluidic device for medical diagnostics
US20030156983A1 (en) * 1998-07-20 2003-08-21 Shartle Robert Justice Fluidic device for medical diagnostics
US20030210287A1 (en) * 1998-07-20 2003-11-13 Harding Ian A. Microdroplet dispensing methods for a medical diagnostic device
US7022286B2 (en) 1998-07-20 2006-04-04 Lifescan, Inc. Fluidic device for medical diagnostics
US20040109790A1 (en) * 1998-07-20 2004-06-10 Shartle Robert Justice Vacuum loaded test strip with stop junction and bypass channel
US20040096980A1 (en) * 2002-03-14 2004-05-20 Harshad Patel Test strip qualification system
US20040106212A1 (en) * 2002-03-14 2004-06-03 Harshad Patel Test strip qualification system
US6682933B2 (en) * 2002-03-14 2004-01-27 Lifescan, Inc. Test strip qualification system
US6835570B2 (en) 2002-03-14 2004-12-28 Lifescan, Inc. Test strip qualification system
US6849456B2 (en) 2002-03-14 2005-02-01 Lifescan, Inc. Test strip qualification system
US20050153457A1 (en) * 2002-03-14 2005-07-14 Harshad Patel Test strip qualification system
US6673617B2 (en) * 2002-03-14 2004-01-06 Lifescan, Inc. Test strip qualification system
US20060057740A1 (en) * 2002-12-02 2006-03-16 Arkray Method for manufacturing tool for analysis
EP2056653A4 (en) * 2006-08-23 2015-02-18 Kondoh Ind Ltd Soft x-ray shielding sheet used in soft x-ray electrostatic removal device and its manufacturing method
EP2056653A1 (en) * 2006-08-23 2009-05-06 Kondoh Industries Ltd. Soft x-ray shielding sheet used in soft x-ray electrostatic removal device and its manufacturing method
US9116089B2 (en) * 2010-11-10 2015-08-25 Boehringer Ingelheim Microparts Gmbh Device for filtering blood
US20130341265A1 (en) * 2010-11-10 2013-12-26 Boehringer Ingelheim Microparts Gmbh Device for filtering blood
US9466104B2 (en) 2012-04-06 2016-10-11 Ixensor Inc. Reading test strip with multiple reaction areas under different exposures or light intensities
US9600878B2 (en) 2012-04-06 2017-03-21 Ixensor Inc. Reading test strip with reaction area, color calibration area, and temperature calibration area
US10921259B2 (en) 2012-12-18 2021-02-16 Ixensor Co., Ltd. Method and apparatus for analyte measurement
US9778200B2 (en) 2012-12-18 2017-10-03 Ixensor Co., Ltd. Method and apparatus for analyte measurement
CN105899935A (en) * 2013-01-07 2016-08-24 安盛生科股份有限公司 Test strips and method for reading test strips
EP2941630A4 (en) * 2013-01-07 2016-08-24 Ixensor Inc Test strips and method for reading test strips
US20170210344A1 (en) * 2014-07-24 2017-07-27 Robert Bosch Gmbh Windscreen wiper device
US20160067709A1 (en) * 2014-09-05 2016-03-10 Htc Corporation Micro-channel module
US20160089671A1 (en) * 2014-09-26 2016-03-31 Picosys Incorporated, a corporation of the State of California DBA Invenios Method and apparatus for taped interlayer flow cell with masking and conductive traces
US9795963B2 (en) * 2014-09-26 2017-10-24 Picosys Incorporated Method and apparatus for taped interlayer flow cell with masking and conductive traces
US10512909B2 (en) 2014-09-26 2019-12-24 Corning Incorporated Method and apparatus for taped interlayer flow cell with masking
US20180353955A1 (en) * 2017-06-08 2018-12-13 Integra Biosciences Ag Sample and reagent reservoir kits and liners with anti-vacuum feature
WO2019141876A1 (en) * 2018-01-22 2019-07-25 Q-Linea Ab Sample holder
CN111683751A (en) * 2018-01-22 2020-09-18 Q-莱纳公司 Sample rack
US11673137B2 (en) 2018-01-22 2023-06-13 Q-Linea Ab Sample holder
US20210164015A1 (en) * 2018-08-17 2021-06-03 Becton, Dickinson And Company Antimicrobial susceptibility testing using microdroplets
CN114624453A (en) * 2022-05-11 2022-06-14 深圳市帝迈生物技术有限公司 Sample analyzer for coagulation and immunity joint detection and detection method thereof

Also Published As

Publication number Publication date
TW539546B (en) 2003-07-01
EP1107004A2 (en) 2001-06-13
HK1036838A1 (en) 2002-01-18
EP1107004B1 (en) 2006-05-03
IL139789A (en) 2005-12-18
US20030210287A1 (en) 2003-11-13
CN1301965A (en) 2001-07-04
DE60027677D1 (en) 2006-06-08
AR026703A1 (en) 2003-02-26
CN1213302C (en) 2005-08-03
PT1107004E (en) 2006-08-31
HK1037723A1 (en) 2002-02-15
RU2256167C2 (en) 2005-07-10
NO320095B1 (en) 2005-10-24
KR20010062005A (en) 2001-07-07
US6830934B1 (en) 2004-12-14
ES2264921T3 (en) 2007-02-01
AU775559B2 (en) 2004-08-05
MXPA00011830A (en) 2002-08-20
AU7189000A (en) 2001-06-14
IL139789A0 (en) 2002-02-10
NO20006106D0 (en) 2000-12-01
JP2001201504A (en) 2001-07-27
DK1107004T3 (en) 2006-08-21
CA2327305A1 (en) 2001-06-03
NO20006106L (en) 2001-06-05
BR0005697A (en) 2001-08-21
SG89361A1 (en) 2002-06-18
ATE325342T1 (en) 2006-06-15
EP1107004A3 (en) 2003-04-16
DE60027677T2 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
US6830934B1 (en) Microdroplet dispensing for a medical diagnostic device
AU752645B2 (en) Fluidic device for medical diagnostics
US6521182B1 (en) Fluidic device for medical diagnostics
EP1069427B1 (en) Initiation of an analytical measurement procedure for blood
TW381044B (en) Process for the production of analytical devices
US5208163A (en) Self-metering fluid analysis device
EP0470438B1 (en) Self-metering fluid analysis device
AU2001280844B2 (en) Strip holder for use in a test strip meter
MXPA02008663A (en) Devices for analyte concentration determination and methods of using the same.

Legal Events

Date Code Title Description
AS Assignment

Owner name: LIFESCAN, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HARDING, IAN A.;SHARTLE, ROBERT JUSTICE;REEL/FRAME:012556/0258

Effective date: 19991130

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION